Gene Therapy Market Size, Share, Growth, Opportunities and Global Forecast to 2028
Gene Therapy Market report published by Value Market Research, which studies the future outlook of the market. It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2022-2028. The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gene therapy market include Biogen (US), Sarepta Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), Novartis AG (Switzerland), Amgen, Inc. (US), Spark Therapeutics, Inc. (US), MolMed S.p.A. (Italy), Orchard Therapeutics plc. (UK), Sibiono GeneTech Co. Ltd. (China), Alnylam Pharmaceuticals, Inc. (US), Human Stem Cells Institute (Russia), AnGes, Inc. (Japan), Dynavax Technologies (US), Jazz Pharmaceuticals, Inc. (Ireland), and Akcea Therapeutics (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments ...